Definition of High Risk/High Response Population for Stroke in Patients with Transient Ischemic Attacks

M. Gent; J. Hirsh

doi:10.1055/s-0039-1687183

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1979; 41(01): 43-57
DOI: 10.1055/s-0039-1687183

Dedication

Schattauer GmbH

Definition of High Risk/High Response Population for Stroke in Patients with Transient Ischemic Attacks

Authors

M. Gent

^*Professor and Chairman, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.
J. Hirsh

²Professor, Department of Pathology, McMaster University, Hamilton, Canada.

Abstract

Full Text

References

References
1 Anturane Reinfarction Trial Research Group. 1978; Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. New England Journal of Medicine 298: 289.
2 Barnett H.J.M.. 1972. Platelets, Drugs and Cerebral Ischemia. In: Hirsh J., Cade J. F., Gallus A. S., and Schonbaum E.. (eds.) Platelets, Drugs and Thrombosis. Karger; Basel.:
3 Beevers D.G., Fairman M.J., Hamilton M., and Harpur J.E.. 1973; Antihypertensive treatment and the course of established cerebral vascular disease. Lancet 1: 1407.
4 Canadian Cooperative Study Group. 1978; A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New England Journal of Medicine 299: 53.
5 Carter A.B.. 1970; Hypotensive therapy in stroke survivors. Lancet 1: 485.
6 Cartlidge N.E.F., Whisnant J.P., and Elveback L.R.. 1977; Carotid and vertebral basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota. Mayo Clinic Proceedings 52: 117.
7 Eisenberg R.L., Nemzek W.R., Moore W.S., and Mani R.L.. 1977; Relationship of transient ischemic attacks and angiographically demonstrable lesions of carotid artery. Stroke 8: 483.
8 Fields W.S., Lemak N. A., Frankowski R. F., and Hardy R.. 1977; Controlled trial of aspirin in cerebral ischemia. Stroke 8: 301.
9 Gerrard J.M., and White J.G.. 1975; The influence of prostaglandin endoperoxides on platelet ultrastructure. American Journal of Pathology 80: 189.
10 Hamberg M., and Samuelsson B.. 1974; Prostaglandin endoperoxides: Novel transformation of arachidonic acid in human platelets. Proceedings of the National Academy of Science of the United States of America 71: 3400.
11 Hamberg M., Svensson J., and Samuelsson B.. 1974; a Prostaglandin endoperoxides: A new concept concerning the mode of action and release of prostaglandins. Proceedings of the National Academy of Science of the United States of America 71: 3824.
12 Hamberg M., Svensson J., Wakabayashi T., and Samuelsson B.. 1974; b Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Science of the United States of America 77: 345.
13 Hamberg M., Svensson J., and Samuelsson B.. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Science of the United Sates of America 72: 2994.
14 Harris W. H., Salzman E. W., Athansoulis C. A., Waltman A. C., and Desanctis R. W.. 1977; Aspirin prophylaxis of venous thromboembolism after total hip replacement. New England Journal of Medicine 297: 1246.
15 Hirsh J., Blajchman M., and Kaegi A.. 1978. The bleeding time. In: Day J., Holmsen H., and Zucker M.. (eds.) Platelet Function Testing. D.H.E.W. Publication, No. (NIH) 78-1087; Washington D.C.:
16 Hypertension - Stroke Cooperative Study Group. 1974; Effect of antihypertensive treatment on stroke recurrence. Journal of the American Medical Association 229: 409.
17 Joint Committee for Stroke Facilities. 1972; 1. Epidemiology for stroke facilities planning. Stroke 3: 360.
18 Kaegi A., Pineo G.F., Shimizu A., Trivedi H., Hirsh J., and Gent M.. 1975; The role of sulfinpyrazone in the prevention of arteriovenous shunt thrombosis. Circulation 52: 497.
19 Kannel W.B., Wolf P.A., Verter J., and McNamara P.M.. 1970; Epidemiologic assessment of the role of blood pressure in stroke: The Framingham Study. Journal of the American Medical Association 214: 301.
20 Kannel W.B.. 1971; Current status of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke 2: 295.
21 Kelton J.G., Carter C., Buchanan M., and Hirsh J.. 1978; Thrombogenic effect of high dose aspirin in injury induced experimental venous thrombosis. Clinical Research 26: 350A.
22 Kinlough-Rathbone R.L., Reimers H.-J., Mustard J. F., and Packham M.A.. 1976; Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science 192: 1011.
23 Kinlough-Rathbone R.L., Packham M.A., Reimers H.-J., Cazenave J.-P., and Mustard J.F.. 1977; Adenine nucleatides in thrombin-degranulated platelets: Effect of prolonged circulation in vivo. Journal of Laboratory and Clinical Medicine 90: 490.
24 Malmsten C., Hamberg M., Svensson J., and Samuelsson B.. 1975; Physiological role of an endoperoxide in human platelets : Hemostatic defect due to platelet cyclo-oxygenase deficiency. Proceedings of the National Academy of Science of the United States of America 72: 1446.
25 Marshall J.. 1964; The natural history of transient ischemic cerebrovascular attacks. Quarterly Journal of Medicine 33: 309.
26 Marshall J., and Kaeser A.C.. 1961; Survival after non-haemorrhagic cerebrovascular accidents. British Medical Journal 2: 73.
27 Mustard J. F., and Packham M. A.. 1970; Factors influencing platelet function-adhesion release and aggregation. Pharmacological Review 22: 97.
28 Packham M.A., Kinlough-Rathbone R.L., Reimers H.-J., Scott S., and Mustard J.F.. 1977. Mechanism of platelet aggregation independence of adenosine diphosphate ADP. In: Smith J.B., and Kocsis C.C.. (eds.) Prostaglandins in Hematology. Spectrum Publications Incorporated; New York:
29 Veterans Administration Cooperative Study Group on Antihypertensive Agents. 1967; Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. Journal of the American Medical Association 202: 116.
30 Veterans Administration Cooperative Study Group on Antihypertensive Agents. 1970; Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. Journal of the American Medical Association 213: 1143.
31 Weiss H.. 1975; Platelet physiology and abnormalities of platelet function. New England Journal of Medicine 293: 531.
32 Whisnant J. P., Matsumoto N., and Elveback L.R.. 1973; Transient cerebral ischemic attacks in a community, Rochester, Minnesota, 1955 through 1969. Mayo Clinic Proceedings 48: 194.
33 Whisnant J. P.. 1974; Epidemiology of stroke: emphasis on transient cerebral ischemic attacks and hypertension. Stroke 5: 68.
34 Whisnant J.P., Cartlidge N.E.F., and Elveback L.R.. 1978; Carotid and vertebral basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence - A population study. Annals of Neurology 3: 107.
35 Wolf P.A., Dawber T.R., Thomas H.E., Colton T., and Nickerson R.J.. 1977; The epidemiology of atherothrombotic brain infarction (ABI): The Framingham Study. Stroke 8: 4.
36 Woolsey R.M., and Henbrook G.W.. 1973; EEG and artériographie findings in carotid artery transient ischemic attacks (TIA’s). Stroke 4: 1.
37 Ziegler D.K., and Hassanein R.S.. 1973; Prognosis in patients with transient ischemic attacks. Stroke 4: 666.